MENU
CAMP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Camp4 Therapeutics (CAMP) Ownership - Who owns Camp4 Therapeutics?
Camp4 Therapeutics Corp is a clinical stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases... Show more
Profile
Industry
N/A
Address
15635 Alton Parkway
Phone
+1 949 600-5600
Employees
644
Web
https://www.calamp.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
31.04M
P/E Ratio
N/A
Total Cash
49.32M
Projected Growth
0.09
Total Debt
7.87M
Revenue
1.51M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
2.45
Total Debt/Equity
N/A
Revenue/Share
0.07 USD as % of share price
Fundamentals
CAMP
Capitalization
31M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
49.3M
Total Cash/Share
2.45
Total Debt
7.87M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
0.09
Revenue/Share (as % of the share price)
0.07%
Revenue
1.51M
ROE
N/A
Book Value
51.6M
P/B Ratio
0.60
Cash Flow
N/A
Earnings
-2.57
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
8.02
Current Revenue Per Employee
15600.00
Dividends Per Share - Security
N/A
EBITDA
-51.63M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-82.47
Shares Held By Institutions
46.4M
Shares Outstanding - Current
20.2M
Total Liabilities
11.2M
Total Volume MTD
N/A
Value
1
Gain YTD
-70.498
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
15635 Alton Parkway
Phone
+1 949 600-5600
Employees
644
Web
https://www.calamp.com